Your request to link to rcsb for Caspase-3
- 1CP3: crystal structure of the complex of apopain with the tetrapeptide inhibitor ace-dvad-fmc (10.1074/JBC.272.10.6539 )
- 1GFW: the 2.8 angstrom crystal structure of caspase-3 (apopain or cpp32)in complex with an isatin sulfonamide inhibitor. (10.1074/JBC.275.21.16007 )
- 1I3O: crystal structure of the complex of xiap-bir2 and caspase 3 (10.1016/S0092-8674(01)00274-4 )
- 1NME: structure of casp-3 with tethered salicylate (10.1038/NBT786 )
- 1NMQ: extendend tethering: in situ assembly of inhibitors (10.1038/NBT786 )
- 1NMS: caspase-3 tethered to irreversible inhibitor (10.1038/NBT786 )
- 1PAU: crystal structure of the complex of apopain with the tetrapeptide aldehyde inhibitor ac-devd-cho (10.1038/NSB0796-619 )
- 1QX3: conformational restrictions in the active site of unliganded human caspase-3 (10.1002/JMR.615 )
- 1RE1: crystal structure of caspase-3 with a nicotinic acid aldehyde inhibitor (10.1021/JM0305523 )
- 1RHJ: crystal structure of the complex of caspase-3 with a pryazinone inhibitor (10.1021/JM0305523 )
- 1RHK: crystal structure of the complex of caspase-3 with a phenyl-propyl- ketone inhibitor (10.1021/JM0305523 )
- 1RHM: crystal structure of the complex of caspase-3 with a nicotinic acid aldehyde inhibitor (10.1021/JM0305523 )
- 1RHQ: crystal structure of the complex of caspase-3 with a bromomethoxyphenyl inhibitor (10.1021/JM0305523 )
- 1RHR: crystal structure of the complex of caspase-3 with a cinnamic acid methyl ester inhibitor (10.1021/JM0305523 )
- 1RHU: crystal structure of the complex of caspase-3 with a 5,6,7 tricyclic peptidomimetic inhibitor (10.1021/JM0305523 )
- 2C1E: crystal structures of caspase-3 in complex with aza-peptide michael acceptor inhibitors. (10.1021/JM0601405 )
- 2C2K: crystal structures of caspase-3 in complex with aza-peptide michael acceptor inhibitors. (10.1021/JM0601405 )
- 2C2M: crystal structures of caspase-3 in complex with aza-peptide michael acceptor inhibitors. (10.1021/JM0601405 )
- 2C2O: crystal structures of caspase-3 in complex with aza-peptide michael acceptor inhibitors. (10.1021/JM0601405 )
- 2CDR: crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. (10.1021/BI060364P )
- 2CJX: extended substrate recognition in caspase-3 revealed by high resolution x-ray structure analysis (10.1016/J.JMB.2006.04.051 )
- 2CJY: extended substrate recognition in caspase-3 revealed by high resolution x-ray structure analysis (10.1016/J.JMB.2006.04.051 )
- 2CNK: crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. (10.1021/BI060364P )
- 2CNL: crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. (10.1021/BI060364P )
- 2CNN: crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. (10.1021/BI060364P )
- 2CNO: crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. (10.1021/BI060364P )
- 2DKO: extended substrate recognition in caspase-3 revealed by high resolution x-ray structure analysis (10.1016/J.JMB.2006.04.051 )
- 2H5I: crystal structure of caspase-3 with inhibitor ac-devd-cho (10.1016/J.JMB.2006.05.041 )
- 2H5J: crystal strusture of caspase-3 with inhibitor ac-dmqd-cho (10.1016/J.JMB.2006.05.041 )
- 2H65: crystal strusture of caspase-3 with inhibitor ac-vdvad-cho (10.1016/J.JMB.2006.05.041 )
- 2J30: the role of loop bundle hydrogen bonds in the maturation and activity of (pro)caspase-3 (10.1021/BI0611964 )
- 2J31: the role of loop bundle hydrogen bonds in the maturation and activity of(pro)caspase-3 (10.1021/BI0611964 )
- 2J32: the role of loop bundle hydrogen bonds in the maturation and activity of(pro)caspase-3 (10.1021/BI0611964 )
- 2J33: the role of loop bundle hydrogen bonds in the maturation and activity of (pro)caspase-3 (10.1021/BI0611964 )
- 2XYG: caspase-3:cas329306 (10.1107/S1744309111018604 )
- 2XYH: caspase-3:cas60254719 (10.1107/S1744309111018604 )
- 2XYP: caspase-3:cas26049945 (10.1107/S1744309111018604 )
- 2XZD: caspase-3 in complex with an inhibitory darpin-3.4 (10.1016/J.STR.2012.12.011 )
- 2XZT: caspase-3 in complex with darpin-3.4_i78s
- 2Y0B: caspase-3 in complex with an inhibitory darpin-3.4_s76r (10.1016/J.STR.2012.12.011 )
- 3DEH: crystal structures of caspase-3 with bound isoquinoline-1,3,4-trione derivative inhibitors (10.1074/JBC.M803347200 )
- 3DEI: crystal structures of caspase-3 with bound isoquinoline-1,3,4-trione derivative inhibitors (10.1074/JBC.M803347200 )
- 3DEJ: crystal structures of caspase-3 with bound isoquinoline-1,3,4-trione derivative inhibitors (10.1074/JBC.M803347200 )
- 3DEK: crystal structures of caspase-3 with bound isoquinoline-1,3,4-trione derivative inhibitors (10.1074/JBC.M803347200 )
- 3EDQ: crystal structure of caspase-3 with inhibitor ac-ldesd-cho (10.1007/S10495-008-0259-9 )
- 3GJQ: caspase-3 binds diverse p4 residues in peptides (10.1007/S10495-009-0333-Y )
- 3GJR: caspase-3 binds diverse p4 residues in peptides (10.1007/S10495-009-0333-Y )
- 3GJS: caspase-3 binds diverse p4 residues in peptides (10.1007/S10495-009-0333-Y )
- 3GJT: caspase-3 binds diverse p4 residues in peptides (10.1007/S10495-009-0333-Y )
- 3H0E: 3,4-dihydropyrimido(1,2-a)indol-10(2h)-ones as potent non- peptidic inhibitors of caspase-3 (10.1016/J.BMC.2009.09.036 )
- 3ITN: crystal structure of pseudo-activated procaspase-3 (10.1042/BJ20090825 )
- 3KJF: caspase 3 bound to a covalent inhibitor (10.1016/J.BBAPAP.2010.05.007 )
- 3PCX: caspase-3 e246a, k242a double mutant (10.1016/J.ABB.2011.01.011 )
- 3PD0: caspase-3 e246a (10.1016/J.ABB.2011.01.011 )
- 3PD1: caspase-3 k242a (10.1016/J.ABB.2011.01.011 )
- 4DCJ: crystal structure of caspase 3, l168d mutant (10.1042/BSR20120009 )
- 4DCO: crystal structure of caspase 3, l168y mutant (10.1042/BSR20120009 )
- 4DCP: crystal structure of caspase 3, l168f mutant (10.1042/BSR20120009 )
- 4EHA: allosteric modulation of caspase-3 through mutagenesis (10.1042/BSR20120037 )
- 4EHD: allosteric modulation of caspase-3 through mutagenesis (10.1042/BSR20120037 )
- 4EHF: allosteric modulation of caspase-3 through mutagenesis (10.1042/BSR20120037 )
- 4EHH: allosteric modulation of caspase-3 through mutagenesis (10.1042/BSR20120037 )
- 4EHK: allosteric modulation of caspase-3 through mutagenesis (10.1042/BSR20120037 )
- 4EHL: allosteric modulation of caspase-3 through mutagenesis (10.1042/BSR20120037 )
- 4EHN: allosteric modulation of caspase-3 through mutagenesis (10.1042/BSR20120037 )
- 4JJE: caspase-3 specific unnatural amino acid peptides (10.1021/CB400209W )
- 4JQY: human procaspase-3, crystal form 1 (10.1073/PNAS.1306759110 )
- 4JQZ: human procaspase-3, crystal form 2 (10.1073/PNAS.1306759110 )
- 4JR0: human procaspase-3 bound to ac-devd-cmk (10.1073/PNAS.1306759110 )
- 4PRY: caspase-8 specific unnatural amino acid peptides (10.1021/CB5004256 )
- 4PS0: caspase-8 specific unnatural amino acid peptides (10.1021/CB5004256 )
- 4QTX: caspase-3 y195a (10.1021/BI500874K )
- 4QTY: caspase-3 e190a (10.1021/BI500874K )
- 4QU0: caspase-3 y195av266h (10.1021/BI500874K )
- 4QU5: caspase-3 t140v (10.1021/BI500874K )
- 4QU8: caspase-3 m61a v266h (10.1021/BI500874K )
- 4QU9: caspase-3 f128a (10.1021/BI500874K )
- 4QUA: caspase-3 y195f (10.1021/BI500874K )
- 4QUB: caspase-3 k137a (10.1021/BI500874K )
- 4QUD: caspase-3 t140f (10.1021/BI500874K )
- 4QUE: caspase-3 y195fv266h (10.1021/BI500874K )
- 4QUG: caspase-3 m61a (10.1021/BI500874K )
- 4QUH: caspase-3 t140g (10.1021/BI500874K )
- 4QUI: caspase-3 f128av266h (10.1021/BI500874K )
- 4QUJ: caspase-3 t140gv266h (10.1021/BI500874K )
- 4QUL: caspase-3 f55w (10.1021/BI500874K )
- 5I9B: caspase 3 v266a (10.1073/PNAS.1603549113 )
- 5I9T: caspase 3 v266c (10.1073/PNAS.1603549113 )
- 5IAB: caspase 3 v266d (10.1073/PNAS.1603549113 )
- 5IAE: caspase 3 v266f (10.1073/PNAS.1603549113 )
- 5IAG: caspase 3 v266q (10.1073/PNAS.1603549113 )
- 5IAJ: caspase 3 v266l (10.1073/PNAS.1603549113 )
- 5IAK: caspase 3 v266s (10.1073/PNAS.1603549113 )
- 5IAN: caspase 3 v266n (10.1073/PNAS.1603549113 )
- 5IAR: caspase 3 v266w (10.1073/PNAS.1603549113 )
- 5IAS: caspase 3 v266y (10.1073/PNAS.1603549113 )
- 5IBC: caspase 3 v266i (10.1073/PNAS.1603549113 )
- 5IBP: caspase 3 v266m (10.1073/PNAS.1603549113 )
- 5IBR: caspase 3 v266k (10.1073/PNAS.1603549113 )
- 5IC4: crystal structure of caspase-3 deve peptide complex (10.1038/CDD.2016.62 )
- 6BDV: crystal structure of caspase 3 s150a (10.1074/JBC.RA117.000728 )
- 6BFJ: caspase-3 mutant - t245d,s249d (10.1074/JBC.RA117.000728 )
- 6BFK: caspase-3 mutant- t245a (10.1074/JBC.RA117.000728 )
- 6BFL: caspase-3 mutant- d9a,d28a,t245d (10.1074/JBC.RA117.000728 )
- 6BFO: caspase-3 mutant- t245d (10.1074/JBC.RA117.000728 )
- 6BG0: caspase-3 mutant - d9a,d28a,s150d (10.1074/JBC.RA117.000728 )
- 6BG1: caspase-3 mutant - d9a,d28a,s150e (10.1074/JBC.RA117.000728 )
- 6BG4: caspase-3 mutant- t152d (10.1074/JBC.RA117.000728 )
- 6BGK: caspase-3 mutant- d9a,d28a,t152d (10.1074/JBC.RA117.000728 )
- 6BGQ: caspase-3 mutant - s150d (10.1074/JBC.RA117.000728 )
- 6BGR: caspase-3 mutant - s150e (10.1074/JBC.RA117.000728 )
- 6BGS: caspase-3 mutant - s150y (10.1074/JBC.RA117.000728 )
- 6BH9: caspase-3 mutant - t152a (10.1074/JBC.RA117.000728 )
- 6BHA: caspase-3 mutant - t152v (10.1074/JBC.RA117.000728 )
- 6CKZ: human caspase-3 in complex with ac-dw3-ke (10.1021/ACSCHEMBIO.9B00564 )
- 6CL0: human caspase-3 in complex with ac-ats009-ke (10.1021/ACSCHEMBIO.9B00564 )
- 6X8I: caspase-3 in complex with ketomethylene inhibitor reveals tetrahedral adduct
- 6X8K: caspase-3 in complex with elongated ketomethylene inhibitor